ArticleHuman vaccines & immunotherapeutics2025

Effectiveness and safety of the recombinant zoster vaccine in adults aged ≥50 years with inflammatory bowel disease.

Hung Fu Tseng et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.